Navigation Links
G-CON Manufacturing and Howorth Air Technology Announce Global Collaboration
Date:3/26/2013

BAYVILLE, N.J. and  COLLEGE STATION, Texas, March 26, 2013 /PRNewswire-iReach/ -- G-CON and Howorth Air Technology have agreed to a global collaboration to offer a flexible pharmaceutical containment solution that will provide a safe and clean environment for GMP therapeutics manufacturing.  Utilizing G-CON's novel, mobile cleanroom PODs™ and Howorth's advanced expertise in engineering clean air and isolator technologies will allow customers to meet safety and regulatory needs without risking process productivity.

(Photo: http://photos.prnewswire.com/prnh/20130326/CG83241)

G-CON's PODs are self-contained, autonomous cleanroom systems for biopharmaceutical processes.  PODs are scalable and repurposeable and can be used in multi-product or individual patient scenarios.  Howorth's clean air engineering is a proven concept which allows for a controlled flow of air, enabling contaminates to be carried away for optimal containment. The combination of G-CON's modular, flexible POD technology and Howorth's world class containment control solutions will provide the biopharmaceutical manufacturing industry with a key resolution that will meet or exceed relevant GMP global standards, while continuing to offer an innovative approach that reduces our clients' time to market. 

Graham Hind , Chief Executive Officer of Howorth Air Technology, states: "G-CON provides a world class innovative solution with a quality and service that present the absolute synergies and ingredients Howorth is proud to be allied with. The collaboration of G-CON, Howorth and their associates will provide the optimum single-source solutions to an unparalleled level of technology, quality and service. This recipe makes a very exciting era for G-CON, Howorth and our customers."

Maik Jornitz , Chief Operating Officer of G-CON Manufacturing, states:  "We are very excited to partner with Howorth Air Technology, a world leading containment and aseptic technologies provider. The combination of G-CON's cleanroom PODs and Howorth's containment options meets current biopharmaceutical industry demands, especially with increasing potency of therapeutic drug products or individual patient therapies."

Effective immediately, G-CON's PODs are made available with Howorth being the preferred service provider in regard to containment products, aseptic solutions, and hospital solutions.

About G-CON
G-CON was founded to address the fact that existing systems and methodologies of constructing biomanufacturing and personalized medicine suites were neither affordable nor flexible enough to meet the rapidly changing market's needs. G-CON's founders have significant experience in designing, building, operating, and maintaining a variety of traditional biomanufacturing facilities. They are familiar with the excessive cost to build, lack of flexibility, and high expense to maintain these traditional facilities and have leveraged this experience to create the G-CON POD™ solution. Moreover, the G-CON team understands that future facility designs must be multipurpose and repurposable, instead of fixed and specialized with ineffective capacity utilization. For more information, please visit the Company's website at www.gconbio.com.

Media Contact: Maik Jornitz , Chief Operating Officer G-CON Manufacturing, 516-356-6869, mjornitz@gconbio.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE G-CON Manufacturing
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Medical Device Manufacturing Coalition Applauds Passage of Medical Device Tax Repeal Amendment
2. Cellnovo Selects Flextronics As Manufacturing And Design Partner
3. Topokine Acquires Exclusive Rights to Revolutionary Technology for Manufacturing Topical Fat-Reducing Medications
4. Neuland Labs Strengthens Commitment to Japanese Market With New Manufacturing Collaboration With Mitsubishi Healthcare Unit API Corporation
5. The Contract Biomanufacturing Market Outlook to 2017
6. MicroVentions New Manufacturing Plant Facility In Costa Rica Celebrates Grand Opening With Inaugural Plant Ceremony
7. Vaccine Manufacturing Technology and Services: World Market 2013-2023
8. Medical Device Contract Manufacturing: World Market Outlook 2013-2023
9. Cedarburg Hauser Granted DEA Registration for Denver Manufacturing Facility
10. Glide Pharma Completes £14.0 Million ($21.4 Million) Fundraising for Scale Up of Drug and Device Manufacturing Processes and Product Development
11. China pharmaceutical manufacturing industry, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... BOSTON , March 27, 2017 ... pharmaceutical company and Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), ... commercialization of innovative therapies based upon tetracycline chemistry, ... sarecycline for the treatment of moderate to severe ... Sarecycline is a once-daily, oral, narrow spectrum tetracycline-derived ...
(Date:3/27/2017)... 2017  Impax Laboratories, Inc. (NASDAQ: IPXL)today announced that ... Bisaro as Impax,s President and Chief Executive Officer ... 27, 2017. Mr. Bisaro will succeed J. Kevin ... Chief Executive Officer since December of 2016. ... experience, Mr. Bisaro, 56, is an accomplished global business ...
(Date:3/27/2017)... March 27, 2017  PhaseRx, Inc. (NASDAQ: PZRX), ... inherited liver diseases in children, today reported financial ... ended December 31, 2016 and provided an update ... continued to make progress during the fourth quarter ... from our non-human primate safety study, and with our ...
Breaking Medicine Technology:
(Date:3/27/2017)... ... March 27, 2017 , ... The ... supply chain professionals, will hold their first Northeast Regional AHVAP Meeting. For 2017, ... , “Increasingly, supply chain and value analysis professionals have a ‘seat at the ...
(Date:3/27/2017)... , ... March 27, 2017 , ... ... Conventional sodium testing methods are complicated and require expert user knowledge. In a ... analytical method dedicated to the simplified, yet highly accurate, determination of sodium. , ...
(Date:3/27/2017)... ... March 27, 2017 , ... From 1999 ... alone responsible for over 33,000 of the 52,404 drug-related deaths in 2015.(2) To ... 1512, which proposes a tax on prescription opioids to fund drug rehabilitation and ...
(Date:3/25/2017)... ... 25, 2017 , ... Getting earned media coverage meaningful for Garden Media Group's ... through the year, Garden Media aims to provide material helpful to clients’ goals and ... pitching client’s key messages to gain coveted media placements, Garden Media wows clients ...
(Date:3/24/2017)... ... March 24, 2017 , ... Mediaplanet today announces distribution of ... current obstacles facing infection prevention and offer strategies for the health care community ... , The print component of “Fighting Infection” is distributed within the Friday, ...
Breaking Medicine News(10 mins):